2Walker MM.Cyclooxygenase-2 expression in early gastric cancer,intestinal metaplasia and Helicobacter pylori infection[J].Eur J Gastroenterol Hepatol,2002,14(4):359-363.
8Kim H,Lim JW,Seo JY,et al.Oxidant-sensitive transcription factor and cyclooxygenase-2 by Helicobactor pylori stimulation in human gastric cancer cells[J].J Environ Pathol Toxicol Oncol,2002,21(2):121-129.
9Masferrer JL,Leahy KM,Koki AT,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res,2000,60(5):1306-1311.
1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量：64
5Jeffrey P,Walterscheid SE. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med,2002,195:171-179.
6Kojima M, Morisaki T, Uchiyama A, et al. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas. Ann Surg Oncol,2001,8:458-465.
7Duff MA, Stapleton P, Mestre JR, et al. Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon [gamma]. Ann Surg Oncol,2003,10(3):305-313.
8Sheng H,Shao J,Morrow JD,et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res,1998,58(2):362-366.
9Han JA, Kim J, Ongusaha P, et al. p53-mediated induction of COX-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J,2002,21:5635-5644.
10Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell,1995,83: 493-501.
